Results 81 to 90 of about 113,966 (168)

Editorial: Adaptive immune regulation of non-alcoholic steatohepatitis (NASH). [PDF]

Front Immunol
Wang H.
europepmc   +1 more source

Diagnostic performance of neck circumference for detecting steatotic liver disease in adults: a systematic review and meta-analysis protocol. [PDF]

BMJ Open
Abdurakhmanova E, Bolatbek A, Zholshybek N, Mustafa Z, Almazan J, Bolla SR.   +5 more
europepmc   +1 more source

Dynamic immune landscape of NAFLD highlights pDCs as predictive biomarkers for disease progression. [PDF]

Front Immunol
Huang G, Xing S, Long Z, Gao W, Kuang S, Liu M, Zou Y, Zhuo C, Dong X.   +8 more
europepmc   +1 more source

Progression of MASH to cirrhosis, decompensation, and mortality, and the utility of NITs for detection and risk stratification. [PDF]

Hepatol Commun
Newsome PN, Sartini C, Morris HL, Gazis D, Mospan AR, Barritt AS, Fried MW, Augustin S, Fraessdorf M, Rudolph B, Loomba R, Sanyal A, TARGET-NASH Investigators.   +12 more
europepmc   +1 more source

Effects of Zaozhu Yinchen Decoction on a Rat Model of Nonalcoholic Steatohepatitis via Regulation of Myeloid-Derived Suppressor Cells. [PDF]

Hepat Med
Zhang W, Wang Y, Liu Y, Zheng X, Wang T, Kwan X, Liu R, Liu Q, Zhuang H, Liang H, Chen S.   +10 more
europepmc   +1 more source

Multi-threshold analysis of the ELF Test versus histology for prognostication of disease progression and regression in MASH. [PDF]

Hepatol Commun
Gee MFW, Fonstad R, De Vol EB, De Vol EB, Brown C, Feld JJ, Patel K, Sanyal AJ.   +7 more
europepmc   +1 more source

From Nash Equilibrium to Social Optimum and Back: A Mean Field Perspective. [PDF]

Appl Math Optim
Carmona R, Dayanıklı G, Delarue F, Laurière M.   +3 more
europepmc   +1 more source

Clinical efficacy of PPAR agonists in the treatment of nonalcoholic fatty liver disease. [PDF]

Front Pharmacol
Li X, Zhang J, Wei B, Tong H.
europepmc   +1 more source

Transcriptomic and Proteomic Analyses Identify THBS2, VWF, NFASC, and AKR1B10 as Diagnostic Biomarkers for Advanced Fibrosis in NAFLD. [PDF]

J Inflamm Res
Ding S, Liu Y, Liu Z, Chu F, Lu B, Xu L.
europepmc   +1 more source

Socioeconomic Factors and Their Role in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Comprehensive Review. [PDF]

Liver Int
Wiering L, Demir M.
europepmc   +1 more source